Skip to main content

Follicular Thyroid Cancer clinical trials at UCSD
1 in progress, 0 open to new patients

  • Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer

    Sorry, in progress, not accepting new patients

    This randomized phase II trial studies how well dabrafenib works with or without trametinib in treating patients with recurrent thyroid cancer. Dabrafenib and trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether dabrafenib is more effective when given with or without trametinib in treating thyroid cancer

    San Diego, California and other locations